Studies have shown that activating transcription factor 3 (ATF3) can mediate ferroptosis of osteoblasts in a high-glucose environment by inhibiting the activity of System Xc-, thereby inducing osteoporosis (27), and more studies have targeted GPX4 to inhibit ferroptosis, with the aim of treating osteoporosis (23, 24). The gene discussed is ATF3; the disease is osteoporosis.